2019
DOI: 10.3205/dgkh000328
|View full text |Cite
|
Sign up to set email alerts
|

Colistin-resistant Pseudomonas aeruginosa clinical strains with defective biofilm formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Based on the literature, the burden of Gram-negative resistance bacteria as a major cause of hospital-acquired infection is increasing day by day [ 7 9 ]. For years, carbapenem was used as one of the last lines of antibiotic therapy for resistant bacteria, especially ESBL producing [ 10 , 11 ]. Resistance to carbapenem leads to serious challenges for physicians and push them to use colistin as the last option, despite of its nephrotoxic effect.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the literature, the burden of Gram-negative resistance bacteria as a major cause of hospital-acquired infection is increasing day by day [ 7 9 ]. For years, carbapenem was used as one of the last lines of antibiotic therapy for resistant bacteria, especially ESBL producing [ 10 , 11 ]. Resistance to carbapenem leads to serious challenges for physicians and push them to use colistin as the last option, despite of its nephrotoxic effect.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the low prevalence of mcr genes in our population might be partially explained by the fact that colistin-resistance in Enterobacterales has been linked mainly to mgrB mutations [ 35 ], rather than to plasmid-mediated genes. In the case of P. aeruginosa , the main drivers of colistin resistance have also been shown to be mainly due to chromosome mutations leading to the overexpression of efflux pumps or defective biofilm formation [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…A number of resistance mechanisms such as target modification, limited permeability of the cell wall, increased activity of efflux pumps and antibiotic hydrolysing enzymes that render antibiotics ineffective have been documented [ 3 , 4 ]. Biofilm formation leads to cross resistance due to low penetration and plays a vital role in the development of preliminary antibiotic resistance mechanisms in A. baumannii and P. aeruginosa [ 5 , 8 ]. The World Health Organization classified carbapenem resistant A. baumannii and carbapenem resistant P. aeruginosa as critical pathogens that require urgent research and development for new drug molecules [ 9 ].…”
Section: Introductionmentioning
confidence: 99%